TABLE 2.
Recently commercialized veterinary bacterial vaccines
| Target pathogen(s) | Target animal | Brand name | Distributor | Characteristic(s) | Reference(s) |
|---|---|---|---|---|---|
| Lawsonia intracellularis | Pigs | Enterisol Ileitis | Boehringer-Ingelheim Vetmedica | Live oral vaccine | 67, 90 |
| Porphyromonas gulae, P. denticanis, and P. salivosa | Dogs | Periovac | Pfizer Animal Health | Killed vaccine against periodontitis | |
| Yersinia ruckeri | Fish | AquaVac ERM | Schering-Plough Animal Health | Killed oral vaccine | 64 |
| Aeromonas salmonicida | Fish | AquaVac Furuvac | Schering-Plough Animal Health | Killed oral vaccine | |
| Vibrio anguillarum | Fish | AquaVac Vibrio | Schering-Plough Animal Health | Killed oral vaccine | |
| Streptococcus equi | Horses | Equilis StrepE | Intervet | Live submucosal vaccine; deletions in aroA gene | 80 |
| Chlamydophila abortus | Sheep | Ovilis Enzovax | Intervet | Live temperature-sensitive mutant strain for subcutaneous or intramuscular injection | 34 |
| Mycoplasma synoviae | Chickens | Vaxsafe MS | Bioproperties | Live temperature-sensitive mutant strain; eye drop administration | 119 |
| Mycoplasma gallisepticum | Chickens | Vaxsafe MG | Bioproperties | Live temperature-sensitive mutant strain; eye drop administration | 10 |
| Bordetella avium | Turkeys | Art Vax | Schering-Plough Animal Health | Live temperature-sensitive mutant strain; spray inhalation or drinking water | 79 |
| Actinobacillus pleuropneumoniae | Pigs | PleuroStar APP | Novartis Animal Health | Recombinant ApxII, TbpB, CysL, OmlA(1), and OmlA(2) proteins | 186 |
| Actinobacillus pleuropneumoniae | Pigs | Porcilis APP | Intervet | Extracted ApxI, ApxII, ApxIII, and outer membrane proteins | 35 |
| Salmonella | Chickens and hens | Megan Vac1 MeganEgg | Lohman Animal Health International | Double gene-deleted S. enterica serovar Typhimurium strain | 5 |
| Brucella abortus | Cattle | RB-51 | Colorado Serum Company CZ Veterinaria | Spontaneous rifampin-resistant rough mutant | 118 |